NYSE: CNSCohen & Steers Inc Stock
$58.49+0.15 (+0.26%)
Updated Nov 30, 2023
CNS Price
$58.49
Fair Value Price
N/A
Market Cap
$2.87B
52 Week Low
$50.05
52 Week High
$78.87
P/E
21.82x
P/B
7.84x
P/S
6.24x
PEG
10.55x
Dividend Yield
3.9%
Revenue
$495.78M
Earnings
$131.73M
Gross Margin
88.8%
Operating Margin
35.54%
Profit Margin
26.6%
Debt to Equity
0.59
Operating Cash Flow
$171M
Beta
1.31
Next Earnings
Jan 23, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CNS Overview
Cohen & Steers, Inc. is an asset management holding company. It takes equity stakes in real estate investment trusts, with holdings in U.S. and international real estate securities. The company also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. Cohen & Steers was founded in 1986 and is headquartered in New York, NY.
Zen Score
–
Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CNS ($58.49) is trading above its intrinsic value of $15.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CNS is good value based on its earnings relative to its share price (21.82x), compared to the US market average (29.24x)
P/E vs Market Valuation
CNS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CNS due diligence checks available for Premium users.
Be the first to know about important CNS news, forecast changes, insider trades & much more!
CNS News
Valuation
CNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
21.82x
Industry
-106.46x
Market
29.24x
CNS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CNS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.84x
Industry
2.13x
CNS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CNS price to earnings growth (PEG)
For valuing profitable companies with growth potential
CNS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CNS's financial health
Profit margin
Revenue
$123.7M
Net Income
$32.1M
Profit Margin
26%
CNS's Earnings (EBIT) of $176.21M... subscribe to Premium to read more.
Interest Coverage Financials
CNS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$673.9M
Liabilities
$217.6M
Debt to equity
0.59
CNS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$74.7M
Investing
-$96.8M
Financing
-$22.1M
CNS's operating cash flow ($171.42M)... subscribe to Premium to read more.
Debt Coverage Financials
CNS vs Asset Management Stocks
Cohen & Steers Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.